https://www.selleckchem.com/pr....oducts/Cryptotanshin
BACKGROUND AND AIMS The prevalence of the non-alcoholic fatty liver disease (NAFLD) in developed countries is up to 30% of the general population, and 50% of patients present type 2 diabetes mellitus (DM2). Fibrosis is the most important prognostic factor in NAFLD. The aim of this study was to search evidence for an early diagnosis of liver fibrosis in subjects with DM2 and to evaluate potential risk and protective factors. METHODS This study was conducted among 160 diabetic patients with NAFLD proven biopsy. Anthropometric ass
Like
Comment
Share
